Bath & Body Works Inc. (BBWI) shares plummeted 5.79% in premarket trading on Thursday, as the retailer of fragrances and scented candles forecasted weaker-than-expected annual results, bracing for the impact of U.S. tariffs on Chinese imports and soft consumer spending.
The company forecasted fiscal 2025 net sales growth of 1% to 3%, largely below analysts' estimates for a 2.8% rise. It also expects full-year 2025 earnings per share (EPS) of $3.25 to $3.60, compared with expectations of $3.62.
Despite the tepid annual guidance, Bath & Body Works reported better-than-expected results for the fourth quarter of fiscal 2024. The company posted an adjusted EPS of $2.09, beating the consensus estimate of $2.04, while revenue of $2.79 billion narrowly topped expectations of $2.78 billion.
Separately, Bath & Body Works announced a share repurchase program of up to $500 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.